Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. Previous experience with molecular biology techniques (Western blots, qPCR/RNAseq), experience with gene editing(CRISPR), and DNA manipulation, are all preferred. The candidate should have hands
-
to numerous satellite sites of care across the region with the goal of providing care ‘close to home’ whenever feasible (https://pediatrics.uchicago.edu/). Our mission is to improve the health of every child
-
RESPONSIBILITIES Maintain mammalian cell cultures in a sterile BSL-2 environment, adhering to safety protocols Perform siRNA knock-down experiments in mammalian cells Perform CRISPR-based gene regulation experiments
-
ambitious research project that bridges translational and clinical science? In our lab, your work directly contributes to science that makes a difference. The Salzer Group combines CRISPR engineering of
-
. Synthetic Biology Applications: Gaining experience in building software tools that support synthetic biology research, including CRISPR/Cas systems, molecular engineering, and vaccine/therapeutic delivery
-
. The project will use quantitative mitochondrial-tracing approaches, including a recently established HiBiT-based platform, live-cell imaging, CRISPR-engineered cancer models and tumour–stromal co-culture
-
, single cell RNA seq Preferred Qualifications: Experience working with rodent models of cancer. Experience performing CRISPR-Cas9 gene knockout in primary cells. Knowledge, Skills and Abilities
-
-domain proteins. Research program The project will establish a targeted CRISPR-based functional screening strategy for LCCL-domain proteins in Cryptosporidium. The postdoctoral researcher will
-
qualifications Experience in CRISPR/Cas9 gene editing, vascular–immune interactions, and preclinical models of intestinal disease or islet transplantation is preferred. Application Requirements Document
-
will work at the interface of discovery and translation, contributing to projects involving CRISPR/Cas9 gene-edited CAR-T cell therapy for hematologic malignancies. Ongoing efforts are directed toward